Levi & Korsinsky Reminds Stellantis Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024 – STLA
NEW YORK, Sept. 20, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Stellantis N.V. (“Stellantis” or the “Company”) (NYSE: STLA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Stellantis investors who were…
Levi & Korsinsky Reminds Methode Electronics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 25, 2024 – MEI
NEW YORK, Sept. 20, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Methode Electronics, Inc. (“Methode Electronics” or the “Company”) (NYSE: MEI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Methode Electronics…
Ford Motor Company Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before October 7, 2024 to Discuss Your Rights – F
NEW YORK, Sept. 20, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Ford Motor Company (“Ford” or the “Company”) (NYSE: F) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ford investors who were adversely affected…
LULU LAWSUIT ALERT: Levi & Korsinsky Notifies Lululemon Athletica Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Sept. 20, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Lululemon Athletica Inc. (“Lululemon” or the “Company”) (NASDAQ: LULU) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lululemon investors who were…
Taylor Swift, Bruce Lee, Lady Gaga, LeBron James, BTS, & Hermès Birkin’s Star in Julien’s Global Auctions in Hong Kong and Beverly Hills
BEVERLY HILLS, Calif., Sept. 20, 2024 /PRNewswire/ — Julien’s Auctions is hosting two extraordinary events this September, celebrating iconic memorabilia and luxury fashion pieces from global legends in sports, music, film, and fashion. Legends in Motion: Hong Kong Exhibition and Auction…
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in Orthofix Medical Inc. Lawsuit – OFIX
NEW YORK, Sept. 20, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Orthofix Medical Inc. (“Orthofix ” or the “Company”) (NASDAQ: OFIX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Orthofix investors who were…
Levi & Korsinsky Reminds CrowdStrike Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2024 – CRWD
NEW YORK, Sept. 20, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in CrowdStrike Holdings, Inc. (“CrowdStrike” or the “Company”) (NASDAQ: CRWD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of CrowdStrike investors…
Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ARDX
NEW YORK, Sept. 20, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardelyx investors who were adversely…
YOFC Unveils MaxBand® OM4 Pro/Ultra Series of Multimode Fibres
Enhancing Data Center Efficiency in the AI Era WUHAN, China, Sept. 20, 2024 /PRNewswire/ — Over the past two decades, the rapid growth in the number of Internet users and connected devices has dramatically boosted traffic to global cloud platforms and enterprise data centres. This surge…
UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late-breaking oral presentation at the EADV Congress 2024
ADESOS Phase 2b results with orismilast in atopic dermatitis (AD) selected as late-breaking oral presentation Additionally, two posters on data from the pioneering use of tape stripping for biomarker analysis in the ADESOS study and additional ADESOS Phase 2b results Orismilast is a next…
UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late-breaking oral presentation at the EADV Congress 2024
ADESOS Phase 2b results with orismilast in atopic dermatitis (AD) selected as late-breaking oral presentation Additionally, two posters on data from the pioneering use of tape stripping for biomarker analysis in the ADESOS study and additional ADESOS Phase 2b results Orismilast is a next…
Europäische Studentengemeinde wächst um 43 %, Dubais führende Bildungsbezirke ziehen Talente aus 170 Ländern an
Bildungscluster der TECOM Group stellt Dubais Rolle im globalen Dialog über Wissen und Innovation auf der EAIE-Konferenz und -Ausstellung in Toulouse, Frankreich, heraus Mehr als 33.500 Lernende aller Altersgruppen sind im Dubai Knowledge Park und in der Dubai International Academic City…